Clinical Trials

80 enrolled

Lymphoma, B-Cell

NCT03375619 2025-11-10

Long-term Follow-up Study of Patients Receiving CAR-T Cells

500 enrolled

Burkitt Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT02633111 2025-11-04

DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas

Active not recruiting

501 enrolled

Aggression, Lymphoma, B-Cell

NCT00626496 2025-10-14

Family Study of Lymphoproliferative Disorders

3,000 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07198373 2025-09-30

Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma

40 enrolled

Lymphoma, B-Cell

NCT06350994 2025-09-02

Cardio CAR-T

60 enrolled

Multiple Myeloma, Cardiomyopathies, Lymphoma, B-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Cardiotoxicity

NCT07101913 2025-08-03

AKI CAR

Active not recruiting

300 enrolled

GenitourinaryLymphoid

Lymphoma, B-Cell, Acute Kidney Injury

NCT06241729 2025-07-31

LBDGCréfract

50 enrolled

Lymphoma, B-Cell

NCT04300998 2025-06-13

Study of CAR-T Therapy in Older Patients

154 enrolled

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

NCT06847529 2025-03-12

Systemic Inflammatory Markers in B-cell Neoplasm

70 enrolled

Lymphoma, B-Cell

NCT06796517 2025-01-28

Immunotherapy in Lymphoma

72 enrolled

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT06721598 2024-12-06

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

LymphoidOther hematologic neoplasm

60 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02298816 2024-10-03

HMvax-Regist

Withdrawn

Smoldering Multiple Myeloma, Influenza, Human, Lymphocytosis, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Pneumonia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Hematologic Neoplasms

NCT06573099 2024-08-27

A Real-World Study on Extranodal Lymphoma

5,000 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06058858 2024-07-17

CMV CAR-T

250 enrolled

Cytomegalovirus Infections, Lymphoma, B-Cell

NCT06497452 2024-07-11

GLOFTST

50 enrolled

Lymphoma, B-Cell

NCT06439173 2024-06-03

Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment

Classical hematologyLymphoid

40 enrolled

Cytopenia, Inflammation, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06142188 2023-11-21

Relmacabtagene Autoleucel in Hematologic Malignancies

150 enrolled

Lymphoma, Follicular, Lymphoma, B-Cell

NCT05495828 2023-10-26

Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors

30 enrolled

Lymphoma, B-Cell

NCT05338879 2023-10-18

FLORA

247 enrolled

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05968001 2023-08-01

Obinutuzumab in Chinese Real-world Patients With iNHL

400 enrolled

Lymphoma, B-Cell

NCT04748185 2023-07-10

Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies

LymphoidOther hematologic neoplasm

358 enrolled

Hodgkin Disease, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT05834426 2023-06-22

Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

50 enrolled

Lymphoma, Non-Hodgkin, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00001582 2023-03-21

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

902 enrolled

Autoimmune Diseases, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT02300402 2023-03-20

ADAMANTIUS

120 enrolled

Hodgkin Disease, Lymphoma, B-Cell

NCT05731375 2023-02-16

MUSCLE

12 enrolled

Lymphoma, B-Cell, Lymphoma, T-Cell

NCT04158128 2023-01-18

The Clinical Implications of Immune Checkpoint Pathways in PCNSL

46 enrolled

Lymphoma, B-Cell

NCT05160064 2022-06-22

Long-term Registry of Patients Treated With Loncastuximab Tesirine

Withdrawn

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03646422 2022-03-31

AEDV Registry of Primary Cutaneous Lymphoma

2,000 enrolled

DermatologicLymphoid

Sezary Syndrome, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Extranodal NK-T-Cell

NCT02840110 2021-10-11

Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product

Terminated

22 enrolled

Multiple Myeloma, Lymphoma, B-Cell

NCT04641806 2021-08-19

LYMPHO-Cov-2

Withdrawn

LymphoidOther hematologic neoplasm

COVID-19, Lymphoma, B-Cell

NCT02928510 2021-07-14

Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

Terminated

1 enrolled

Signs and Symptoms, Digestive, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT03000192 2021-03-17

HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life

BreastGynecologicLymphoid

3,000 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Vulvar Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms

NCT03681938 2018-09-24

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

183 enrolled

Lymphoma, B-Cell

NCT02354846 2018-07-17

An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study)

112 enrolled

Lymphoma, B-Cell

NCT00359411 2017-07-02

Genetic Studies of X-linked Lymphoproliferative Disease

12 enrolled

Infectious Mononucleosis, Lymphoproliferative Disorders, Lymphoma, B-Cell, Epstein-Barr Virus Infections, Genetic Diseases, X-Linked

NCT02992223 2016-12-14

Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT

58 enrolled

Recurrence, Lymphoma, B-Cell

NCT02791217 2016-06-06

Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool

100 enrolled

Hodgkin Disease, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, B-Cell

NCT01459653 2016-01-11

Monitor-GCSF

1,496 enrolled 120 charts

BreastClassical hematologyGenitourinaryGynecologicLymphoidPlasma cellThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Lymphoma, B-Cell, Febrile Neutropenia

NCT01478269 2011-11-23

ProDLBCL

1,927 enrolled